Self-monitoring Blood Glucose Market to Grow with a CAGR of 8.61% through 2030

Increasing healthcare expenditure and growing elderly population is expected to drive the Global Self-monitoring Blood Glucose Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Global Self-monitoring Blood Glucose Market - Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Self-monitoring Blood Glucose Market stood at USD 10.28 Billion in 2024 and is anticipated to grow with a CAGR of 8.61% in the forecast period through 2030. The market growth is driven by the rising awareness of preventive care for diabetes and the introduction of new products. Diabetes is a significant and escalating global issue, characterized by insufficient insulin production by the pancreas leading to increased blood glucose levels. According to the International Diabetes Federation, there were approximately 537 million diagnosed cases of diabetes in 2021, and this number is projected to reach 643 million by 2030 and 783 million by 2045.

Chronic diabetes significantly impacts the body's ability to regulate blood sugar levels, necessitating regular monitoring for effective management and prevention of complications. Consequently, there is a notable demand in the market for blood glucose monitoring devices. According to the World Health Organization (WHO), there are 422 million diabetic patients worldwide, resulting in 1.5 million annual deaths. This escalating prevalence of diabetes underscores the need for continuous monitoring of blood glucose levels and adjustment of medication dosages.’ Diabetes is a chronic disease affecting approximately 8.5% of the global population, generating an annual expenditure of $1.3 trillion.

The pre-diabetic condition highlights the importance of early diagnosis and monitoring for effective blood sugar management, thereby driving the demand for advanced blood glucose level monitoring devices. Senseonics' Eversense, the first FDA-approved system with a fully implantable sensor capable of measuring glucose levels for up to 90 days, includes an intelligent transmitter that relays real-time data to a mobile app for visualization through charts and graphs. The Combo Glucometer (CoG) offers a non-invasive solution for glucose monitoring, utilizing a digital image sensor to assess reflected light from tissue and employing proprietary algorithms for accurate blood glucose level measurements. Abbott has introduced the FreeStyle Libre flash glucose monitoring system, a user-friendly and portable point-of-care system that allows patients to monitor readings using a handheld scanner. Currently available in Europe and the United States, this product boasts a 25% cost advantage over standalone continuous glucose monitoring (CGM) systems in a favorable reimbursement environment. The introduction and high adaptability of these innovative devices are expected to propel the Blood Glucose monitoring market at a significantly high growth rate.

Blood glucose monitoring (BGM) devices offer valuable assistance to diabetic patients in multiple ways. These devices enable patients and healthcare professionals to detect abnormal blood glucose levels, allowing for necessary adjustments in treatment and timely confirmation of acute hypoglycemia or hyperglycemia. They also promote patient education about diabetes management and encourage the adoption of healthier habits. Blood glucose devices are available in various sizes, price ranges, testing times, and levels of user-friendliness. Consumer awareness regarding the benefits of these devices has increased, particularly due to the emphasis placed on virtual clinics and telemedicine for diabetic management during the pandemic. By aiding in glycemic control and empowering patients, blood glucose monitoring devices have significantly transformed diabetes care.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Self-monitoring Blood Glucose Market.”

The Global Self-monitoring Blood Glucose Market is segmented into product, application, end user, regional distribution, and company. 

Based on application, the Type 2 diabetes category shows the fastest growth over the forecast period. It is a chronic, lifelong condition that affects the processing and monitoring of sugar levels. Type 2 diabetes is the most common form of diabetes, accounting for the majority of diabetes cases globally. The rising prevalence of Type 2 diabetes, particularly due to lifestyle factors like sedentary habits, unhealthy diets, and obesity, is contributing to the expanding market for self-monitoring blood glucose devices. Effective management of Type 2 diabetes requires regular blood glucose monitoring. Self-monitoring blood glucose devices play a vital role in helping individuals with Type 2 diabetes track their glucose levels and make necessary adjustments to their treatment plans, contributing to the market growth.

Based on Region, Asia Pacific is currently the fastest-growing region in the Global Self‑Monitoring Blood Glucose (SMBG) Market, fueled by a confluence of demographic, policy, and technological factors: The region shoulders a significant diabetes burden, with over 60% of the global diabetic population residing in Asia Pacific—China and India alone account for more than half of these cases. This high prevalence has driven governments to introduce targeted initiatives: China’s National Diabetes Prevention and Treatment Program (launched in 2022) and India’s National Diabetes and Obesity Programme have prioritized diabetes screening and improved access to glucometers. Health infrastructure improvements and rural outreach are also key, as seen in ICMR-supported campaigns for house-to-house glucose monitoring across hundreds of villages. These efforts bridge gaps in urban–rural healthcare, increasing SMBG accessibility in underserved areas. Technological integration is another major driver. The adoption of smart glucometers, which pair with mobile apps and offer AI-driven insights, is rising sharply—Samsung Medical Center reports younger users preferring connected devices, while Indian startups like Wellthy and BeatO leverage telehealth platforms to boost self-monitoring.

Major companies operating in Global Self-monitoring Blood Glucose Market are:

• Abbott Laboratories
• Medtronic plc
• F. Hoffmann-La Roche Ltd
• Ascensia Diabetes Care
• Dexcom, Inc.
• Sanofi
• Novo Nordisk
• Insulet Corporation
• Ypsomed Holdings
• Glysens Incorporated

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The growth observed in the global self-monitoring blood glucose market can be attributed to factors such as the rising prevalence of obesity, the growth of emerging markets, rapid urbanization, and increased healthcare expenditure. Moving forward, the increasing incidence of diabetes, an aging population, government initiatives, and the utilization of blood glucose monitoring devices in fitness, dieting, and wellness are expected to drive the market. However, potential challenges that could hinder the growth of the self-monitoring blood glucose (SMBG) devices market in the future include rising interest rates. Continuous glucose monitoring (CGM) devices automatically measure glucose levels and store the readings in a monitor. Typically, these devices consist of a sensor worn on the body that obtains frequent glucose readings automatically. The data can be manually scanned or wirelessly transmitted to a nearby receiver for display. This enables patients and healthcare providers to assess patterns in glucose fluctuations, facilitating informed decisions regarding nutrition, physical activity, and medication. In recent years, the continuous glucose monitoring segment has experienced significant growth due to the increasing adoption of these devices. Furthermore, advancements in technology and design have facilitated their wider acceptance among patients and healthcare providers. The market is expected to further expand as these devices become more user-friendly, less intrusive, and more cost-effective.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Self-monitoring Blood Glucose Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Self-monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By End User (Hospitals, Home Settings, and Diagnostic Centers), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Self-monitoring Blood Glucose Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Self-monitoring Blood Glucose Market..

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: sales@techsciresearch.com

Website: www.techsciresearch.com